After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.

The temporary halt to investigate reported neurovascular events comes two months after Johnson & Johnson won FDA approval for ...